3-methylglutaconic acid has been researched along with Smith-Lemli-Opitz Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryan, RO; Su, B | 1 |
| Connor, WE; Jacobs, MD; Merkens, LS; Pappu, AS; Roullet, JB; Steiner, RD; Winter, R | 1 |
1 review(s) available for 3-methylglutaconic acid and Smith-Lemli-Opitz Syndrome
| Article | Year |
|---|---|
Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.
Topics: Acetyl Coenzyme A; Acyl Coenzyme A; Animals; Cardiolipins; Chorea; Citric Acid Cycle; Glutarates; Humans; Metabolism, Inborn Errors; Mitochondrial Proteins; Optic Atrophy; Phosphatidylglycerols; Smith-Lemli-Opitz Syndrome; Spastic Paraplegia, Hereditary; Terpenes | 2014 |
1 other study(ies) available for 3-methylglutaconic acid and Smith-Lemli-Opitz Syndrome
| Article | Year |
|---|---|
No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Topics: Child; Cholesterol; Cholesterol, Dietary; Dehydrocholesterols; Diet, High-Fat; Dietary Supplements; Female; Glutarates; Humans; Hydroxymethylglutaryl CoA Reductases; Male; Mevalonic Acid; Oxidoreductases Acting on CH-CH Group Donors; Simvastatin; Smith-Lemli-Opitz Syndrome; Terpenes | 2012 |